New shot aims to shrink dangerous heart plaque
NCT ID NCT06788431
Summary
This study is testing a new injectable drug, IMC-001, to see if it can safely reduce the volume of a dangerous type of soft plaque in the heart arteries of patients who recently had a heart attack or unstable angina. The trial will enroll 30 participants who are already receiving standard medications after a stent procedure. Researchers will use heart scans to measure changes in plaque and compare results between those receiving the drug and those receiving a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Renji Hospital,Shanghai
RECRUITINGShanghai, Shanghai Municipality, China
-
The First Affiliated Hospital of Nanyang Medical College
RECRUITINGNanyang, Henan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.